Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$25.68 - $35.59 $37.4 Million - $51.9 Million
-1,457,280 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$24.9 - $40.26 $15,238 - $24,639
-612 Reduced 0.04%
1,457,280 $42.7 Million
Q3 2021

Nov 15, 2021

BUY
$25.48 - $37.34 $19,925 - $29,199
782 Added 0.05%
1,457,892 $37.1 Million
Q2 2021

Aug 16, 2021

BUY
$32.46 - $43.42 $23,371 - $31,262
720 Added 0.05%
1,457,110 $51 Million
Q1 2021

May 14, 2021

BUY
$38.94 - $50.85 $69,352 - $90,563
1,781 Added 0.12%
1,456,390 $59.3 Million
Q4 2020

Feb 12, 2021

BUY
$37.65 - $63.77 $44,728 - $75,758
1,188 Added 0.08%
1,454,609 $63 Million
Q3 2020

Nov 13, 2020

BUY
$52.76 - $74.49 $43,579 - $61,528
826 Added 0.06%
1,453,421 $80.1 Million
Q2 2020

Aug 14, 2020

BUY
$48.73 - $81.82 $7,163 - $12,027
147 Added 0.01%
1,452,595 $91.7 Million
Q1 2020

May 15, 2020

BUY
$41.72 - $87.2 $41.1 Million - $85.9 Million
984,928 Added 210.67%
1,452,448 $74.2 Million
Q4 2019

Feb 18, 2020

BUY
$45.7 - $81.86 $4 Million - $7.16 Million
87,520 Added 23.03%
467,520 $37.2 Million
Q3 2019

Nov 14, 2019

BUY
$45.35 - $57.91 $9.98 Million - $12.7 Million
220,000 Added 137.5%
380,000 $18.4 Million
Q1 2018

May 15, 2018

BUY
$39.6 - $65.9 $6.34 Million - $10.5 Million
160,000 New
160,000 $7.73 Million

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Capital World Investors Portfolio

Follow Capital World Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.